Thermo Fisher partners EDB for US$130m sterile fill-and-finish facility
Add BT as a preferred source
Singapore
THERMO Fisher Scientific's plans to build a new US$130 million sterile fill-and-finish facility in Singapore, with the support of the Singapore Economic Development Board (EDB), will create some 300 jobs once operational in 2022.
The investment is an "important addition to the manufacturing capacity needed by global pharmaceutical and vaccine companies in the ongoing fight against Covid-19," EDB chairman Beh Swan Gin said in a press release late last week.
TRENDING NOW
Lamborghini-driving boss of Eminent Frog Porridge charged with S$3.8 million tax evasion, money laundering
Malaysian tycoon Vincent Tan’s sell-downs point to pruning rather than an exit plan
Palm oil stocks set to surge as Indonesia said to be scaling back export overhaul: analysts
Soon Su Lin to step down as Frasers Property Singapore CEO; Tan Wee Hsien named successor
